Microsporidial AIDS cholangiopathy due to Encephalitozoon intestinalis: case report and review

R A Sheikh1, T P Prindiville, S Yenamandra

  • 1Department of Internal Medicine, University of California Davis, Sacramento 95932, USA.

Insights

Encephalitozoon intestinalis, a microsporidian, caused AIDS cholangiopathy in an immunocompromised patient. Early albendazole treatment improved symptoms and CD4 count, but bile duct damage persisted.

Area of Science:

  • Medical Mycology
  • Gastroenterology
  • Infectious Diseases

Background:

  • Microsporidia are opportunistic pathogens, frequently affecting immunocompromised individuals, particularly those with Acquired Immunodeficiency Syndrome (AIDS).
  • Enterocytozoon bieneusi and Encephalitozoon intestinalis are the primary microsporidian species causing disease in AIDS patients, with diarrhea being the most common symptom.
  • Encephalitozoon intestinalis has been implicated in disseminated infections, including cholangitis, a condition affecting the bile ducts.

Observation:

  • A case of AIDS cholangiopathy presented with abdominal pain and cholestatic liver tests, mimicking sclerosing cholangitis.
  • Initial diagnostic tests, including bile and stool samples, were negative for microsporidia. Routine microscopy of biopsy specimens also failed to identify the organism.
  • Encephalitozoon intestinalis spores were definitively identified in bile duct biopsies using specialized staining and electron microscopy.

Findings:

  • Albendazole therapy successfully eradicated Encephalitozoon intestinalis, leading to clinical improvement and an increased CD4 count.
  • Despite successful infection eradication, the cholangiographic findings showed progressive bile duct injury, indicating irreversible damage.
  • The delay in albendazole administration, requiring compassionate use approval, may have contributed to the persistent bile duct damage.

Implications:

  • This case highlights Encephalitozoon intestinalis as an unusual cause of sclerosing cholangitis in AIDS patients.
  • Early diagnosis and prompt treatment with albendazole are crucial for managing microsporidial infections, though they may not reverse established biliary damage.
  • Management of such cases may necessitate interventions like biliary sphincterotomy and stent placement to address progressive bile duct stricturing.

Related Concept Videos

Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
Toxoplasmosis01:28

Toxoplasmosis

Toxoplasmosis, a zoonotic disease caused by the protozoan Toxoplasma gondii, poses significant public health challenges globally due to its high seroprevalence and varied clinical manifestations. As an obligate intracellular parasite, T. gondii can infect all warm-blooded vertebrates, but felids are its only definitive hosts, shedding unsporulated oocysts into the environment. Humans typically acquire the infection through ingestion of tissue cysts in undercooked meat or oocysts from...
Giardiasis01:12

Giardiasis

Giardiasis is a globally prevalent intestinal infection caused by the protozoan parasite Giardia duodenalis (also known as G. lamblia or G. intestinalis). This flagellated protozoan is the most frequently identified intestinal parasite in the United States and worldwide. Transmission primarily occurs via the fecal-oral route, with infection arising from ingestion of water or food contaminated with cysts. Individuals in low-resource settings, international travelers, outdoor enthusiasts, daycare...
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...